Based on data from animal and clinical studies, studies have shown that a subpopulation of MDD patients, both in animal models and clinical trials, exhibits increased plasma TNF-α levels, and blocking TNF-α improves depressive symptoms [45]. This evidence concerns the gene TNF and major depressive disorder.